LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Organizer
C&EN
C&EN
Chemical & Engineering News (C&EN) is the flagship magazine of the American Chemical Society, an organization with over 157,000 members in over 100 countries. "Like" C&EN if you're a professional looking for chemistry news or are simply a chemistry fan.
Tags
Academy/Principles
LinkedIn Logo

Accelerating Drug Discovery: Enhanced Chemistry Strategies for NCEs, ADCs, and Emerging Modalities

RECORD | Already taken place We, 17.9.2025
Join Eurofins Discovery experts to explore AI-driven, high-throughput chemistry strategies accelerating novel therapeutics, from ADCs to degraders and small molecules.
Go to the webinar
C&EN: Accelerating Drug Discovery: Enhanced Chemistry Strategies for NCEs, ADCs, and Emerging Modalities
C&EN: Accelerating Drug Discovery: Enhanced Chemistry Strategies for NCEs, ADCs, and Emerging Modalities

The need for efficient and innovative drug discovery chemistry strategies to support novel modalities like Degraders, ADCs (Antibody-Drug Conjugates), and other complex therapeutics has never been greater.

In this webinar, Eurofins Discovery’s global team of chemistry experts will share how integrated, AI-enhanced workflows and high-throughput methods are accelerating the development of robust candidates. Drawing on our proven expertise in medicinal, computational, synthetic, and analytical chemistry, we’ll explore how our streamlined, automation-driven approach enables the rapid delivery of potent, high-quality compounds, while ensuring IP protection and cost efficiency.

The session will highlight real-world applications of these capabilities, including the story of an A2A receptor program that progressed from early-stage discovery to preclinical candidate nomination for Parkinson’s Disease, and was later successfully repositioned for Immuno-Oncology. We’ll also explore how our chemistry strategies are enabling the development of complex modalities such as degraders and ADCs, demonstrating the scalability and precision of our approach across diverse therapeutic platforms.

Whether you're working on traditional small molecules or next-generation biologically targeted therapies, this session will help you identify practical strategies to reduce risk, enhance translational success, and accelerate your discovery pipeline.

Key Learning Objectives:
  • Leverage integrated chemistry platforms support to accelerate iteration and decision-making across modalities, including NCEs, ADCs, and hybrids
  • Apply innovative approaches to payload-linker synthesis and conjugation in ADCs development
  • Discover advanced tools and techniques to speed up hit-to-lead transitions and lead optimization
  • Explore case studies that demonstrate successful implementation of discovery strategies
  • Enhance efficiency, reduce attrition, and improve candidate quality through streamlined chemistry workflows

Presenter: Sujay Basu, Ph.D. (Director, Discovery Chemistry, Eurofins Discovery)

Presenter: Matthew Horwitz, Ph.D. (Project Manager & Head of Scale-up Laboratory, Eurofins Discovery)

C&EN
LinkedIn Logo
 

Related content

Analysis of Anti-Degradant Additive (6PPD) and its Transformation Product 6PPD-Quinone in Tire Rubber Using an Integrated HPLC System

Applications
| 2026 | Shimadzu
Instrumentation
HPLC
Manufacturer
Shimadzu
Industries
Energy & Chemicals

Performance Evaluation of Microbial Identification Using a Benchtop MALDI-TOF MS

Applications
| 2026 | Shimadzu
Instrumentation
MALDI, LC/MS, LC/TOF, Software
Manufacturer
Shimadzu
Industries
Pharma & Biopharma, Food & Agriculture

Achieving Sharp Peaks and High Sensitivity with Nexera X4

Applications
| 2026 | Shimadzu
Instrumentation
HPLC
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

Achieving Solvent Reduction and Lower Running Costs with Nexera X4

Applications
| 2026 | Shimadzu
Instrumentation
HPLC, Consumables, LC columns
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

Maximizing Operational Productivity through Ultra-Fast Analysis with Nexera X4

Applications
| 2026 | Shimadzu
Instrumentation
HPLC
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike